NEWRON PHARMACEUTICALS S.P.A. EUR0.20 financial statements, including revenue, expenses, profit, and loss
The total revenue of 0QOI for the last semiannual is 3.41 M CHF, and it's 36.98% lower compared to the previous semiannual. The net income of H2 23 is -8.88 M CHF.